FDA Adverse Event Injury Summary report: N

VASER ASPIRATING CANNULA

MDR report key: 14718539 · Received June 16, 2022

Report

Report Number
3011423170-2022-00078
Event Type
Injury
Date Received
June 16, 2022
Report Date
May 5, 2022
Manufacturer
SOLTA MEDICAL, INC
Product Code
QPB
PMA / PMN Number
K110306
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE PRODUCT HAS BEEN RETURNED AND WILL BE EVALUATED SHORTLY. THE INVESTIGATION IS ONGOING.

Additional Manufacturer Narrative · 0

THE CANNULA WAS RETURNED FOR EVALUATION. SERVICE WAS ABLE TO CONFIRM THAT THE CANNULA WAS BROKEN AT THE BASE. THE TREND ANALYSIS, RISK ANALYSIS AND/OR DIRECTIONS FOR USE REVIEW WERE CONSIDERED ACCEPTABLE, WITH THE PRODUCT PERFORMING WITHIN ANTICIPATED RATES. COMPLAINT TYPE IDENTIFIED WITHIN RISK ANALYSIS AND PERFORMING WITHIN ANTICIPATED RATE. NO CORRECTIVE ACTION IS REQUIRED.

Additional Manufacturer Narrative · 0

CORRECTION: REVISED H6 INVESTIGATION CONCLUSIONS CODE FROM 4307 TO 4315 CORRECTION TO H11 NARRATIVE: CONFIRMED DAMAGED CANNULA. CANNULA APPEARED TO BE SEPARATED FROM THE HUB. THERE WERE NO OBVIOUS SIGN OF BOND DEGRADATION FROM A CHEMICAL SOLUTION BETWEEN THE LUMAN AND HUB THAT MIGHT HAVE BEEN USED DURING CLEANING PROCESS. EVALUATION FOUND THE DIMENSIONS OF THE CANNULA WERE WITHIN THE PRODUCT DESIGN. BASED ON THE AVAILABLE INFORMATION, NO CAUSAL FACTORS CAN BE DETERMINED, AND NO CONCLUSIONS CAN BE FOUND.

Description of Event or Problem · 0

A USER FACILITY REPORTED THAT DURING TREATMENT WITH A VASERLIPO SYSTEM THEY HAD A CANNULA BREAK LEADING TO A DELAY IN SURGERY OF 20 MINUTES WHILE THE PATIENT WAS UNDER GENERAL ANESTHESIA. THE CANNULA DID NOT BREAK WHILE INSIDE OF THE PATIENT. THERE WAS NO PATIENT IMPACT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1795719 VASER ASPIRATING CANNULA SYSTEM, SUCTION, LIPOPLASTY FOR REMOVAL QPB SOLTA MEDICAL, INC 810GHBU3726VXNR 222

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Required Intervention